Our latest research result is published in Advanced Science

Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform!

We are thrilled to announce the publication of our paper, ” An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers,” in the prestigious Advanced Science journal. Led by Dr. Hsing-Mao Chu, CEO of T-E Meds, this research brings us to achieve new breakthroughs in ADC technology and clinical medical applications.

Link to article:


Scroll to Top